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control rates and may ultimately improve OS. The 
combination of surgery followed by RT appears to be the 
current standard of care.  
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Purpose or Objective: To elucidate the radiobiological 
effects of stereotactic radiosurgery (SRS) on brain metastases 
using autopsy cases. 
 
Material and Methods: From 1995 to 2013, 9 brain specimens 
from 3 patients were available. They underwent autopsy 
after SRS in our hospital. These specimens were all brain 
metastases. The timing of autopsy was from 7 days to 20 
months (median 10 months) after SRS. The 9 tumors received 
a margin dose of 16–20 Gy (median 20 Gy) at the 40–75% 
isodose line (median 40%), with a maximal dose of 16–50 Gy 
(median 45 Gy). Histopathological investigations were 
performed. The specimens were fixed in 20% neutral buffered 
formaldehyde and embedded in paraffin. Hematoxylin-eosin, 
Azan-Mallory, and Bodian stains were used. 
Immunohistochemical reactions included glial fibrillary acidic 
protein, alpha-smooth muscle actin, CD34, and CD68 
antigens. Ki67 and p53 reactions were also used. 
 
Results: The first case was a 59-year-old man diagnosed with 
2 brain metastases from renal cell carcinoma. Both lesions 
were irradiated with SRS. He received SRS 4 times after the 
first SRS. At 1 week after the last SRS, he died from 
carcinomatous lymphangiosis. The second case was a 63-year-
old man diagnosed with 2 brain metastases from lung cancer. 
Both lesions were irradiated with SRS plus whole brain 
radiotherapy (WBRT). Seven months later, he died from 
carcinomatous peritonitis. The third case was a 35-year-old 
woman diagnosed with 2 brain metastases from breast 
cancer. Both lesions were irradiated with WBRT plus SRS. 
When one of the lesions enlarged 1 year later, repeated SRS 
was performed. At 7 months after reirradiation, she died 
from carcinomatous lymphangiosis. In the first case, necrosis 
and viable tumor cells were observed mainly in the center of 
the lesion at 1 week after SRS, while apoptosis and fibrosis 
were observed in a small part of the lesion. Glial cells and 
neutrophilic leukocytes had accumulated around the lesion. 
In the lesions at 2 months after SRS, tumor cells and fibrosis 
were not observed; only macrophages and glial cells were 
observed in the SRS irradiated field. In the second case, 
fibrosis was observed at the periphery of the center necrotic 
region at 7 months after SRS. In the third case, almost all 
parts of the lesions were replaced with fibrosis at 19 months 
after SRS, while small foci of viable tumor cells, a large 
number of glial cells, and macrophages were observed around 
the fibrotic area. 
 
Conclusion: In the tumors, apoptosis was only observed at 1 
week after SRS. The time of fibrosis initiation varied in each 
case. Around the tumors, neutrophilic leukocytes and glial 
cells accumulated within 1 week after SRS. Macrophages 
accumulated at least 2 months after SRS. Stromal changes 
remained for a considerable period of time. It was 
remarkable that fibrosis occurred very soon after SRS, and 
other observations were generally compatible with previous 
reports. 
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Purpose or Objective: The goal of surgical treatment of 
meningiomas is the total resection of the tumour. The 
complete removal of petroclival meningiomas can be difficult 
because of their proximity to cranial nerves. Stereotactic 
radiosurgery (SRS) is a well established treatment for many 
patients with intracranial meningiomas, either in the 
exclusive or adjuvant setting. However, SRS of large 
meningiomas might be associated with significant morbidity. 
Under these circumstances s-SRS has the potential to deliver 
sharply focused high doses per fraction without increasing the 
risk of toxicity.The aim of this study is to prospectively 
evaluate the feasibility of s-SRS for petroclival meningiomas, 
including large volume lesions. 
 
Material and Methods: Between September 2011 and 
October 2013 at our Institute, s-SRS using the CyberKnife was 
prospectively performed on 30 patients (24 women and 6 
men, men, mean age 57 years) with petroclival meningiomas. 
Patients with atypical or malignant meningiomas and those 
who had received prior radiotherapy were excluded. The 
average tumor volume was 11,86 cm3 (range 2,2–126,3 cm3); 
the average tumor prescription dose was 24,4 Gy, the number 
of fraction was 4 or 5. 
 
Results: After a median follow-up of 30 months (range 13-36 
months ) the overall tumour control rate was 100% (25 
patients with stable disease, 3 patients with partial response 
and 2 patients with complete response). Tumor control rates 
at 2 and 3 years was 100%. Among 28 patients who were 
symptomatic before staged radiosurgery, neurological follow-
up showed an improvement in 43%, stable clinical course in 
43% and a persistent deterioration of clinical symptoms in 
14% of the patients. A transient neurological deterioration 
was observed in 11% of patients within the first year after 
treatment. 
 
Conclusion: Our findings show that s-SRS using the 
CyberKnife is a safe and effective option in the treatment of 
large-volume petroclival meningiomas. A good tumour control 
and a low morbidity rate was achieved in our series, either as 
a primary or adjuvant approach. Long-term follow-up is 
warranted to confirm these results. 
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Purpose or Objective: Frameless radiosurgery (SRS) plays an 
important role in the management of acoustic neuromas. This 
retrospective study aims to evaluate tumor control using this 
technique.  
 
Material and Methods: Thirty four patients with unilateral 
acoustic neuromas (vestibular schwannomas) who underwent 
linear accelerator-based frameless SRS at low dose (12 Gy) to 
the tumor from July 2008 to February 2015 were evaluated. 
Twenty-one patients were male and 13 patients were female. 
The median age was 62 years (range 23-84) with a median 
follow-up period of 12.4 months (range 1-60). Treatment 
volume was 0.1 to 3.8 cm3 (median 0.93 cm3 ). 
 
Results: Preliminary results from follow-up magnetic 
resonance imaging (MRI) showed: the tumor of 15 patients 
decreased in diameter, no changes was found in 14 and the 
tumor increased slightly in only one patient. All patients are 
alive, except for 1p who died from intercurrent disease 2 
years after radiosurgery. Among 23p with acufeno, full 
improvement was demonstrated in four. There were no 
reported complications related to treatment.  
